Mechanisms of pain and their therapeutic implications

Journal of the American Veterinary Medical Association

Volumn 219, Issue 10, 2001, Pages 1346-1356

  Muir III, William W ^a   Woolf, Clifford J ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTIHISTAMINIC AGENT; BRADYKININ; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYTOKINE; GLUCOCORTICOID; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 6; KAINIC ACID; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NERVE GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROSTAGLANDIN E2; SEROTONIN; SODIUM CHANNEL; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIA; HYPERALGESIA; INFLAMMATION; NERVE CONDUCTION; NERVE INJURY; NERVE PROJECTION; NEUROPATHY; NOCICEPTION; PAIN; PERCEPTION; REVIEW; SENSITIZATION; SENSORY NERVE; SIGNAL TRANSDUCTION; SPINAL CORD; TISSUE INJURY;

EID: 0035890024     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.219.1346     Document Type: Review

References (92)

1. Carstens E, Moberg GP. Recognizing pain and distress in laboratory animals. ILAR 2000;41:62-70.
2. Chapman CR, Garvin J. Suffering: the contribution of persisting pain. Lancet 1999;353:2233-2237.
3. Moberg GP. When does stress become distress? Lab Anim Sci 1999;28:422-426.
4. Clark JD, Raper DR, Calpin JP. Animal well-being III. An overview of assessment. Lab Anim Sci 1997;47:580-585.
5. Clark JD, Raper DR, Calpin JP. Animal well-being IV. Specific assessment criteria. Lab Anim Sci 1997;47:586-597.
6. Flecknell P. Assessment and alleviation of post-operative pain. Anim Welfare Information Center Newslett 1997/1998;8:1-14.
7. Holton LL, Scott EM, Nolan AM, et al. Comparison of three methods used for assessment of pain in dogs. J Am Vet Med Assoc 1998;212:61-66.
8. Mathews KA. Pain assessment and general approach to management. Management of pain. Vet Clin North Am 2000;30: 729-755.
9. Cambridge AJ, Tobias KM, Newberry RC, et al. Subjective and objective measurements of postoperative pain in cats. J Am Vet Med Assoc 2000;217:685-690.
10. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105: 83-107.
11. Clark JD, Raper DR, Calpin JP. Animal well-being I. General considerations. Lab Anim Sci 1997;47:564-570.
12. Clark JD, Raper DR, Calpin JP. Animal well-being II. Stress and distress. Lab Anim Sci 1997;47:571-579.
13. Roughan JV, Flecknell PA. Behavioral effects of laparotomy and analgesic effects of ketoprofen and carprofen in rats. Pain 2001;90:65-74.
14. Classification of chronic pain: a list with definitions and a note on usage. In: Merskey H, Bogduk N, eds. International Association for the Study of Pain (IASP) task force on taxonomy. 2nd ed. Seattle: IASP Press, 1994:209-214.
15. Willis AD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997;14:2-31.
16. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 1990;73:308-327.
17. Woolf CJ, Chong M-S. Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993;77:362-379.
18. Koltzenburg M. The changing sensitivity in the life of the nociceptor. Pain 1999;6(suppl):S93-S102.
19. Cook AJ, Woolf CJ, Wall PD, et al. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C primary afferent input. Nature 1987;325:151-153.
20. Pockett S. Spinal cord synaptic plasticity and chronic pain. Anesth Analg 1995;80:173-179.
21. Kandel ER. Nerve cells and behavior. In. Kandel ER, Schwartz JH, Jessel TM. eds. Principles of neural science. 3rd ed. Norwalk, Conn: Appleton & Lange, 1991;19-32.
22. Byers MR, Bonica JJ. Peripheral pain mechanisms and nociceptor plasticity. In: Loeser JD, Butler SH, Chapman CR, et al, eds. Bonicas management of pain. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001;26-72.
23. Raja SN, Meyer RA, Ringkamp M, et al. Peripheral neural mechanisms of nuciception. In: Wall PD, Melzack R, eds. Textbook of pain. 4th ed. Philadelphia: Churchill Livingstone Inc, 1999;11-58.
24. Doubell TP, Mannion RJ, Woolf CJ. The dorsal horn: state-dependent sensory processing, plasticity and generation of pain. In: Wall PD, Melzack R, eds. Textbook of pain. 4th ed. Philadelphia: Churchill Livingstone Inc, 1999;165-182.
25. Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 1998;20:629-632.
26. Hunt SP, Rossi J. Peptide and non-peptide containing unmyelinated primary afferents: the parallel processing of nociceptive information. Philos Trans R Soc Lond B Biol Sci 1985;308: 283-289.
27. Tominga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998;21:531-543.
28. Garcia-Anoveros J, Samad TA, Zuvela-Jelaska L, et al. Transport and localization of the DEG/BNaC ion channel BNaClα to peripheral mechnosensory terminals of dorsal root ganglia neurons. J Neurosci 2001;21:2678-2686.
29. + channels in pain pathways. Trends Pharmacol Sci 2001;22:27-31.
30. Waxman SG, Dib-Haji S, Cummins TR, et al. Sodium channels and pain. Proc Natl Acad Sci U S A 1999;96:7635-7639.
31. Piomelli D, Gluffrida A, Calignano A, et al. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000;21;218-224.
32. Gee NS, Brown JP, Dissanayake VUK, et al. The novel anti-convulsant drug, gabapentin (Neurontin), binds to the α2d subunit of a calcium channel. J Biol Chem 1996;271:5768-5776.
33. Willis WD, Coggeshall RE. Sensory mechanisms of the spinal cord. New York: Plenum Press, 1991.
34. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 1952;96:415-466.
35. Sandkuhler J. The organization and function of endogenous antinociceptive systems. Prog Neurobiol 1996;50:49-81.
36. Chery N, DeKoninck Y. GABA(B) receptors are the first target of released GABA at lamina I inhibitory synapses in rat spinal cord. J Neurophysiol 2000;84:1006-1011.
37. Cao YQ, Manthy PW, Carlson EJ, et al. Primary afferent tachykinins are required to experience moderate to intensive pain. Nature 1998;382:390-394.
38. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D aspartate acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-299.
39. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-1768.
40. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991;14:219-245.
41. Baba H, Kohno T, Okamoto M, et al. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol 1998;508:83-93.
42. Baba H, Shimoji K, Yoshimura M. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 1) Anesthesiology 2000;92:474-484.
43. Baba H, Goldstein PA, Okamoto M, et al. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 2). Anesthesiology 2000;92:485-492.
44. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, eds. Textbook of pain. Edinburgh: Churchill Livingstone Inc, 1999;309-329.
45. Chapman CR. Limbic processes and the affective dimension of pain. In: Carli G, Zimmerman M, eds. Towards the neurobiology of chronic pain. New York: Elsevier Publishers BV, 1996;110:63-81.
46. LeDoux JE, Iwata I, Cicchetti P, et al. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988;8:2517-2529.
47. Charney DS, Grillon C, Bremner JD. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (part I). Neuroscientist 1998;4:35-44.
48. Charney DS, Grillon C, Bremner JD. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (part II). Neuroscientist 1998;4:122-132.
49. Treede RD, Meyer RA, Raja SN, et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Progress in Neurobiology 1992;38:397-421.
50. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75:125-131.
51. Levine JD, Reichling DB. Peripheral mechanisms of inflammatory pain. In: Wall PD, Melzack R, eds. Textbook of pain. 4th ed. Philadelphia: Churchill Livingstone Inc, 1999;59-84.
52. Vergnolle N, Wallace JL, Bunnett NW, et al. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001;22:146-152.
53. Vane JR, Bakhle VS, Botting RM. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
54. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1β-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-475.
55. Neugebauer V, Schaible HG, Schmidt RF. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflugers Arch 1989;415:330-335.
56. England S, Bevan SJ, Docherty RJ. Prostaglandin E2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglia neurons via the cyclic AMP-protein kinase A cascade. J Physiol 1996;495:429-440.
57. Handwerker HO, Reeh PW. Pain and inflammation, in Proceedings. 6th World Congr Pain 1991;59-70.
58. Xu GY, Huang LY, Zhao ZQ. Activation of silent mechanoceptive cat C and A sensory neurons and their substance P expression following peripheral inflammation. J Physiol 2000; 528:339-348.
59. Schaible HG, Schmidt RF. Activation of groups III and IV sensory units in medial articular nerve by local mechanical stimulation of knee joint. J Neurophysiol 1983;49:35-44.
60. Woolf CJ, Ma Q-P, Allchorne A, et al. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996;16:2716-2723.
61. Lindsay KM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362-364.
62. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor. A heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
63. Woolf CJ. Excitability changes in central neurons following peripheral damage: role of central sensitization in the pathogenois of pain. In: Willis WD Jr, ed. Hyperalgesia and allodynia. New York: Raven Press, 1992;221-243.
64. -9 block of NMDA-receptor channels as a mechanism of modulation. Nature 1992;356:521-523.
65. Martin WJ, Maimberg AB, Basbaum AI. PKCγ contributes to a subset of the NMDA-dependent spinal circuits that underlie injury-induced persistent pain. J Neurosci 2001;21:5321-5327.
66. Watkins LR. Glial activation: a driving force for pathological pain. Trends Neurosci 2001;24:450-455.
67. Ma Q-P, Woolf CJ. Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain 1996;67:97-106.
68. Baba H, Doubell TP, Woolf CJ. Peripheral inflammation facilitates Ab fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord. J Neurosci 1999;19:859-867.
69. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-979.
70. Gjerstad J, Tjolsen A, Hole K. Induction of long-term potentiation of single wide dynamic range neurons in the dorsal horn is inhibited by descending pathways. Pain 2001;91:263-268.
71. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effect of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989;37:111-123.
72. Xu X, Puke MJ, Verge VM, et al. Up-regulation of cholecystokinin in primary neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett 1993;152:129-133.
73. Woolf CJ, Shortland P, Coggesshall RE. Peripheral nerve injury triggers central sprouting of myclinated afferents. Nature 1992;355:75-77.
74. Neumann S, Doubell TP, Leslie TA, et al. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996;384:360-364.
75. Oddiah D, Anand P, McMahon SB, et al. Rapid increase in NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 1998;9:1455-1458.
76. Koltzenburg M, Bennett DL, Shelton DL, et al. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur J Neurosci 1999;11: 1698-1704.
77. Ru-Rong J, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001;8: 1-10.
78. Impey S, Mark M, Villacres LC, et al. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CAl of the hippocampus. Neuron 1996;16:973-982.
79. Tale S, Benn S, Hick C, et al. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat Neurosci 1998;1:653-655.
80. Michael GJ, Averill S, Shortland PJ, et al. Axotomy results in major changes in BDNF expression by dorsal root ganglion cells: BDNF expression in large trkB and trkC cells, in pericellular baskets, and in projections to deep horn and dorsal column nuclei. Eur J Neurosci 1999;11:3539-3551.
81. Black JA, Cummin TR, Plumpton C, et al. Upregulation of silent sodium channels after peripheral hut not central nerve injury in DRG neurons. J Neurophysiol 1999;82:2776-2785.
82. Mannion RJ, Doubell TP, Coggeshall RE, et al. Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsiacin to the sciatic nerve. J Neurosci 1996;16:5189-5195.
83. Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999;20:329-337.
84. Kehlet H, Dahl JB. The value of multimodal or balanced analgesia in postoperative pain treatment. Anesth Analg 1993;77:1048-1056.
85. Honore P, Rogers SD, Schwei MJ, et al. Murine models of inflammatory, neuropathic and cancer pain each generate a unique set neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000;98:585-598.
86. Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
87. Field MJ, McCleary S, Hughs J, et al. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999;80:391-398.
88. Diener KM. Bisphosphonates for controlling pain from metastatic bone disease. Am J Health Syst Pharm 1996;53:1917-1927.
89. Turk DC, Okifuju A. Pain terms and taxonomies of pain. In: Loeser JD, ed. Bonicas management of pain. 3rd ed. Philadelphia: Lippinant Williams & Wilkins, 2001;17-25.
90. Jensen MP, Smith DG, Ehde DM, et al. Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 2001;91:317-322.
91. Woof CJ, Max MB. Mechanism-based pain diagnosis Anesthesiology 2001;95:241-249.
92. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995;310:452-454.